BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18485022)

  • 1. Involution of infantile haemangiomas after imiquimod 5% cream.
    Barry RB; Hughes BR; Cook LJ
    Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
    Ho NT; Lansang P; Pope E
    J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
    Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
    Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars.
    Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X
    Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
    Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
    Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
    Welsh O; Olazarán Z; Gómez M; Salas J; Berman B
    J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of imiquimod in treating infantile haemangiomas: cause for concern?
    Hussain W; Judge MR
    Clin Exp Dermatol; 2009 Oct; 34(7):e257. PubMed ID: 19508566
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
    Senchak AJ; Dann M; Cable B; Bessinger G
    Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.
    Hazen PG; Carney JF; Engstrom CW; Turgeon KL; Reep MD; Tanphaichitr A
    Pediatr Dermatol; 2005; 22(3):254-6. PubMed ID: 15916578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
    Ray CM; Kluk M; Grin CM; Grant-Kels JM
    Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.
    Tiodorovic-Zivkovic D; Zalaudek I; Longo C; De Pace B; Albertini G; Argenziano G
    Eur J Dermatol; 2012; 22(4):579-80. PubMed ID: 22652500
    [No Abstract]   [Full Text] [Related]  

  • 12. Infantile hemangioma: clinical resolution with 5% imiquimod cream.
    Martinez MI; Sanchez-Carpintero I; North PE; Mihm MC
    Arch Dermatol; 2002 Jul; 138(7):881-4; discussion 884. PubMed ID: 12071813
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasodilatory adverse events associated with topical imiquimod 5 percent cream.
    Jacobs AA; Snavely N; Markus J; Rosen T
    Dermatol Online J; 2008 Apr; 14(4):4. PubMed ID: 18627726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcerated infantile hemangioma treated with imiquimod.
    Mascarenhas R; Guiote V; Agro J; Henrique M
    Dermatol Online J; 2011 Sep; 17(9):13. PubMed ID: 21971278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study.
    Rosen T; Harting M; Gibson M
    Dermatol Surg; 2007 Apr; 33(4):427-31; discussion 431-2. PubMed ID: 17430376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 0.5% topical timolol cream on regression of superficial infantile haemangioma in the involuting phase: a prospective, randomized, self-controlled study.
    Ying H; Han Y; Chen Z; Yu Z; Chang L; Ma G; Chen Q; Chang S; Qiu Y; Lin X
    Eur J Dermatol; 2020 Oct; 30(5):591-595. PubMed ID: 33185527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma.
    McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I
    Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
    Miller AK; Dusing R; Meggison A; Aires D
    J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod--proposal of a therapeutic schedule.
    Sendagorta E; Herranz P; Feito M; Ramírez P; Floristán U; Feltes R; Benito DM; Casado M
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):490-2. PubMed ID: 19840203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of imiquimod for the treatment of infantile hemangiomas].
    Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.